We further found that the regulatory effects of ADGRG6 overexpression on proliferation, migration, invasion and the expression of the EMT- and immune-related markers of PAAD cells was mediated by mutated p53. This evidence concerns the gene ADGRG6 and pancreatic adenocarcinoma.